Main > ONCOLOGY (**) > Gastric Cancer>MET HER2+ > TREAT.: > USA. M. PD-1 Receptor Binding MAb+

---

USA. M. PD-1 Receptor Binding MAb+'s subsections
(*) USA Approval Date: 2021. 05.05.
+TrastuzyMAb+CT
Company
Generic Name: PembrolizuMAb
HER: Human Epidermal growth factor>
PD: Programmed cell Death
TradeMark
Web-Site

USA. M. PD-1 Receptor Binding MAb+'s products
This section has no products